SCHEMBL4649110

SCHEMBL4649110

CCOc1ccc2cncnc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.70
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 2/20 0.48
CYP19A1 P11511 1/20 0.48
MAPT P10636 1/20 0.46
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
NQO1 P15559 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KMT2A Q03164 1/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30504578 1.00 EGFR (0.70) EGFRCYP11B1CYP11B2CYP19A1MAPT
SCHEMBL28243443 0.86 EGFR (0.70) EGFRCYP11B1CYP11B2CYP19A1MAPT
SCHEMBL668493 0.82 EGFR (1.00) EGFRCYP11B1CYP11B2LMNAALDH1A1
SCHEMBL29517021 0.82 EGFR (1.00) EGFRCYP11B1CYP11B2LMNAALDH1A1
SCHEMBL30241125 0.82 EGFR (1.00) EGFRCYP11B1CYP11B2LMNAALDH1A1
SCHEMBL2637564 0.82 EGFR (0.69) EGFRHDAC1HDAC6HDAC5PDGFRB
SCHEMBL13837704 0.82 EGFR (0.73) EGFRTSHRHSD17B10HDAC1HDAC6
Hydrochloric Acid SCHEMBL28023744 0.81 EGFR (0.96) EGFRCYP11B1CYP11B2LMNAALDH1A1
SCHEMBL7580057 0.80 EGFR (0.60) EGFRLMNAHDAC1HDAC6HDAC5
SCHEMBL29831918 0.79 EGFR (0.59) EGFRCYP3A4TSHRNCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104069112-A Substituted piperidino-dihydrothienopyrimidines BOEHRINGER INGELHEIM INT 2014-10-01 CN disclosed
EP-1962960-A1 MICRONIZATION METHOD Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2008-09-03 EP disclosed
WO-2007068655-A1 MICRONIZATION METHOD BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-06-21 WO disclosed